CHIMERA BIOENGINEERING
They aspire to control the immune system. By the time a patient is sitting in front of an oncologist, cancer has evaded their immune system. Chimeric antigen receptor T-cells (CARs) are reprogrammed immune cells, hot-wired to circumvent immune-evasion. Clinical trials for CARs against liquid tumor cancers, like acute lymphoblastic leukemia and lymphoma, have shown transformative results for patients unresponsive to standard therapy. However, limited efficacy against solid tumor cancers, life... -threatening toxicities, and limited persistence are impediments to these therapies making a wider impact on cancer patients. Chimera Bioengineering solves the challenges of CARs with drug-responsive gene regulators, which allow us to re-program the "software" of the immune system. They design CAR behavior that promises to minimize toxicity, maximize efficacy and extend persistence so that CARs can lead to cures.w
CHIMERA BIOENGINEERING
Social Links:
Industry:
Bioinformatics Biotechnology Genetics Health Care
Founded:
2015-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.chimera.bio
Total Employee:
11+
Status:
Active
Contact:
(310)497-0736
Total Funding:
30.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business GoDaddy DNS Google GStatic Google Static Content
Similar Organizations
ACT Genomics
ACT Genomics is a cancer molecular information service company teamed up with experts with multiple years’ experience in oncology
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
HelixNano
Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases.
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Fabric Genomics (formerly Omicia)
Global healthcare platform for genomics-driven precision medicine. Fabric' proven AI algorithms power genomic insights.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Founder
Investors List
Asian Fund For Cancer Research
Asian Fund For Cancer Research investment in Grant - Chimera Bioengineering
Sand Hill Angels
Sand Hill Angels investment in Convertible Note - Chimera Bioengineering
Life Science Angels
Life Science Angels investment in Venture Round - Chimera Bioengineering
Sand Hill Angels
Sand Hill Angels investment in Series A - Chimera Bioengineering
Sand Hill Angels
Sand Hill Angels investment in Seed Round - Chimera Bioengineering
Kairos Ventures
Kairos Ventures investment in Seed Round - Chimera Bioengineering
Sand Hill Angels
Sand Hill Angels investment in Convertible Note - Chimera Bioengineering
The Angels' Forum
The Angels' Forum investment in Convertible Note - Chimera Bioengineering
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-28 | Chimera Appoints New CEO, Wins AFCR BRACE Award, and Accelerates towards the Clinic with TME-Modifying CAR-T Therapies for Solid Tumors |
Official Site Inspections
http://www.chimera.bio
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Chimera Bioengineering"
Chimera Bioengineering - Crunchbase Company Profile …
Chimera Bioengineering solves the challenges of CARs with drug-responsive gene regulators, which allow us to re-program the "software" of the immune system. They design CAR behavior that promises to minimize toxicity, …See details»
Science - Chimera Bio
Chimera has created novel CAR-T cells with genetic engineering technology to address the challenges in the field of cell therapy. Learn more about our scientific pipeline targeting solid tumors. ... The current state of engineered cell …See details»
Chimera Bioengineering Company Profile 2024: Valuation, Funding ...
Chimera Bioengineering General Information Description. Developer of gene therapeutics designed to re-program the immune system and treat cancer. The company's therapeutics are …See details»
Chimera Bioengineering - A Kairos Ventures Portfolio …
Chimera Bioengineering is a biotherapeutics company building RNA based gene regulatory systems for chimeric antigen receptor CAR-T cell therapeutics with …See details»
Asian Fund for Cancer Research Announces Chimera …
Apr 28, 2022 HONG KONG--(BUSINESS WIRE)--Chimera Bioengineering has been selected as the winner of the Asian Fund for Cancer Research’s (AFCR) 2021 BRACE Award Venture Competition—a first-of-its-kind ...See details»
Chimera Appoints New CEO, Wins AFCR BRACE Award, and …
Apr 28, 2022 AFCR’s BRACE Award is a first-of-its-kind program for early stage oncology technology companies focused on Asian-prevalent cancers. With this honor, AFCR, Bluedot …See details»
Chimera Bioengineering Company Profile - Craft
Chimera Bioengineering has 5 employees at their 1 location. See insights on Chimera Bioengineering including office locations, competitors, revenue, financials, executives, …See details»
Asian Fund for Cancer Research Announces Chimera ... - BioSpace
Apr 28, 2022 HONG KONG--(BUSINESS WIRE)-- Chimera Bioengineering has been selected as the winner of the Asian Fund for Cancer Research’s (AFCR) 2021 BRACE Award Venture …See details»
Announcement: Chimera Bioengineering is the 2021 …
CONTACTS:Asian Fund for Cancer ResearchBradley Gillenwater, Senior Director for Corporate EngagementE-mail: [email protected] Chimera BioengineeringVlad Hogenhuis, M.D., CEOE-mail: [email protected] Little …See details»
ChimeraBio - Crunchbase Investor Profile & Investments
ChimeraBio is a biological investment firm specialized in seed and early stage venture investments.See details»
Chimera Appoints New CEO, Wins AFCR BRACE Award, and …
Apr 28, 2022 With this honor, AFCR, Bluedot Bio, and other new investors contributed $7.5 million of new capital, joining Chimera’s existing investors, including Viking Global Investors, …See details»
Ben Wang | Chimera Bioengineering
Dr. Ben Wang is co-founder and COO of Chimera Bioengineering. Prior to his role at Chimera, he was co-founder at Svaya Nanotechnologies, which developed and commercialized …See details»
Chimera (genetics) - Wikipedia
Two-colored rose chimera. A genetic chimerism or chimera (/ k aɪ ˈ m ɪər ə / ky-MEER-ə or / k ɪ ˈ m ɪər ə / kim-EER-ə) is a single organism composed of cells with more than one distinct …See details»
Toward developing human organs via embryo models and …
Jun 20, 2024 Developing organs fit for transplantation remains a challenging goal in regenerative medicine. In this perspective, what is known about early human development is summarized …See details»
People | Chimera Bio
At Chimera, we believe that a candidate is more than a resume. Human beings have stories, and sometimes those stories aren’t highlighted by the school you went to or the experience you …See details»
Plant chimeras: The good, the bad, and the ‘Bizzaria’
Nov 1, 2016 Both mericlinal and periclinal chimeras can arise from this technique and the nature of the chimera depends on the organization of the SAM. This method was inadvertently used …See details»
Chimera (mythology) - Wikipedia
According to Greek mythology, [1] the Chimera, Chimaera, Chimæra, or Khimaira (/ k aɪ ˈ m ɪər ə, k ɪ-/ ky-MEER-ə, kih-; Ancient Greek: Xίμαιρα, romanized: Chímaira, lit. 'she-goat') [2] was a …See details»
Gus Zeiner - Chimera Bio
Dr. Gusti Zeiner is CSO and co-founder of Chimera where he applies his scientific expertise to address the challenges patients face in current treatment paradigms. Prior to his role at …See details»
Updates | Chimera Bio
News, updates, and dialogue. All Posts; Posts; SearchSee details»